NSC |
Compound |
Enrichment |
Correlation |
NSC 734758 |
Null |
0.00526022686151165 |
0.28975577 |
NSC 602613 |
Null |
0.00526022686151168 |
0.48425091 |
NSC 724794 |
5-Benzyl-9-hydroxy-5H-indeno[1,2-b]indol-10-one |
0.00526022686151168 |
-0.053377367 |
NSC 734913 |
Null |
0.00559873245069072 |
0.22988469 |
NSC 744469 |
3-cyano-3,3-diphenylpropyl 4-(3-[(11aS)-7-methoxy-5-oxo-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-8-yl]oxypropyl)-1-piperazinecarbodithioate |
0.00559873245069072 |
0.053814053 |
NSC 107043 |
Null |
0.00559873245069076 |
0.27224471 |
NSC 132791 |
Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo |
0.00559873245069076 |
0.45669979 |
NSC 133118 |
2H-1,2,3-Triazolo[4,5-d]pyrimidin-7-amine, 2-.beta.-D-ribofuranosyl- (9CI) |
0.00559873245069076 |
-0.0046059793 |
NSC 276361 |
1H-Pyrrole-3,4-dimethanol, 1-(4-butylphenyl)-2,5-dimethyl-, bis(methylcarbamate) (ester) |
0.00559873245069076 |
-0.046897665 |
NSC 603084 |
2-Butene, 2,3-dibromo-1,4-bis[(3,4-dichloro-2,5-dihydro- 2-oxofuran-5-yl)oxy]-, (E)- |
0.00559873245069076 |
0.23124952 |